Data from: Global distribution of Chelonid fibropapilloma-associated herpesvirus among clinically healthy sea turtles

• Main Authors: Alfaro-Núñez, Alonzo, Bertelsen, Mads Frost, Bojesen, Anders Miki, Rasmussen, Isabel, Zepeda-Mendoza, Lisandra, Olsen, Morten Tange, Gilbert, Marcus Thomas Pius
• Format: Dataset
• Language: unknown
• Published: Data Archiving and Networked Services (DANS) 2014
• Subjects: Life sciences; medicine and health care; Co-evolution; sea turtles; herpesvirus; fibropapillomatosis; tumours; latency; CFPHV; Western Pacific; Caribbean; Turks and Caicos Islands; North Atlantic; Mediterranean; Western Africa; Gulf and Indian Ocean; present; Chelonid fibropapilloma-associated herpesvirus; Chelonia mydas; Dermochelys coriacea; Caretta caretta; Eretmochelys imbricata; Lepidochelys olivacea; envir; manag; Indian; Pacific
• Online Access: https://doi.org/10.5061/dryad.8r082

Background: Fibropapillomatosis (FP) is a neoplastic disease characterized by cutaneous tumours that has been documented to infect all sea turtle species. Chelonid fibropapilloma-associated herpesvirus (CFPHV) is believed to be the aetiological agent of FP, based principally on consistent PCR-based detection of herpesvirus DNA sequences from FP tumours. We used a recently described PCR-based assay that targets 3 conserved CFPHV genes, to survey 208 green turtles (Chelonia mydas). This included both FP tumour exhibiting, and clinically healthy (i.e. presenting no visual evidence of neoplasia) individuals. An additional 129 globally distributed clinically healthy individual sea turtles; representing four other species were also screened. Results: CFPHV DNA sequences were obtained from 37/37 (100%) FP exhibiting green turtles, and 45/300 (15%) clinically healthy animals spanning all five species. Although the frequency of infected individuals per turtle population varied considerably, most global populations contained at least one CFPHV positive individual, with the exception of various turtle species from the Arabian Gulf and Northern Indian Ocean, as well as hawksbill turtles (Eretmochelys imbricata) from Puerto Rico. Haplotype analysis of the different gene markers clustered the CFPHV DNA sequences for two of the markers (UL18 and UL22) in turtles from Turks and Caicos separate to all others, regardless of host species or geographic origin. Conclusion: Presence of CFPHV DNA within globally distributed samples for all five species of sea turtle was confirmed. While 100 % of the FP exhibiting green turtles yielded CFPHV sequences, surprisingly, so did 15% of the clinically healthy turtles. We hypothesize that turtle populations with zero (0%) CFPHV frequency may be attributed to possible environmental differences and/or genetic resistance in these individuals. Our results provide first data on the prevalence of CFPHV among seemingly healthy turtles; a factor that may not be directly correlated to the disease ...